Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924194 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
A NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02924194 is a NA study that was terminated before completion, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 3 participants.
The verdict
NCT02924194, a NA study, was terminated before completion, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation of the nucleus basalis of Meynert (also called the "nbM") at improving memory in Parkinson's disease patients with mild cognitive impairments and memory difficulties. Patients with Parkinson's disease (PD) that are eligible for Deep Brain Stimulation (DBS) therapy for improvement of their motor symptoms and with evidence of mild cognitive impairments and memory difficulties will be enrolled.
Interventions
- DEVICE stimulation ON
- DEVICE stimulation OFF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02924194
The ClinicalTrials.gov registry entry for NCT02924194 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stimulation ON is the first listed.
NCT02924194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02924194 about?
NCT02924194 is a clinical study titled "Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease". The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation of the nucleus basalis of Meynert (also called the "nbM") at improving memory in Parkinson's disease patients with mild cognitive impairments and memory difficulties. Patients with Parkinson's disease (PD...
What is the current status of trial NCT02924194?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-09. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT02924194?
The interventions under investigation include: stimulation ON (DEVICE), stimulation OFF (DEVICE).
Who is sponsoring clinical trial NCT02924194?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.